Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Shares Outstanding (Weighted Average) (2022 - 2025)

Historic Shares Outstanding (Weighted Average) for Envoy Medical (COCH) over the last 4 years, with Q3 2025 value amounting to $21.9 million.

  • Envoy Medical's Shares Outstanding (Weighted Average) rose 1737.85% to $21.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.9 million, marking a year-over-year increase of 1737.85%. This contributed to the annual value of $18.8 million for FY2024, which is 5282.51% up from last year.
  • Latest data reveals that Envoy Medical reported Shares Outstanding (Weighted Average) of $21.9 million as of Q3 2025, which was up 1737.85% from $21.4 million recorded in Q2 2025.
  • In the past 5 years, Envoy Medical's Shares Outstanding (Weighted Average) ranged from a high of $42.5 million in Q1 2022 and a low of $10.1 million during Q2 2023
  • Moreover, its 4-year median value for Shares Outstanding (Weighted Average) was $18.6 million (2024), whereas its average is $20.6 million.
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first tumbled by 7618.22% in 2023, then surged by 8374.74% in 2024.
  • Over the past 4 years, Envoy Medical's Shares Outstanding (Weighted Average) (Quarter) stood at $10.1 million in 2022, then increased by 21.46% to $12.3 million in 2023, then soared by 52.83% to $18.8 million in 2024, then increased by 16.29% to $21.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $21.9 million in Q3 2025, compared to $21.4 million in Q2 2025 and $21.3 million in Q1 2025.